New Biotic
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17875 Von Karman Ave Ste 150, Irvine, Ca...Phone Number
(949) 556-8739Website
www.newbiotic.comRevenue
$6.7 MillionIndustry
About New Biotic
New Biotic Org Chart
Is New Biotic your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at New Biotic
New Biotic, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on New Biotic recently announced quarterly report
Check if New Biotic has recently received funding, and reach out quickly before it becomes old news!
Check out if New Biotic is spiking on competitors!
Click to see if New Biotic had a recent Job posting/layoffs
Product Launch: Get notified when New Biotic launches new products
Funding: Get notified immidiatlly once New Biotic has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at New Biotic
Find 3 more new buyers
Compare Similar Companies to New Biotic
Compare insights from companies similar to New Biotic, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
New Biotic is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
New Biotic is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about New Biotic.
New Biotic Tech Stack
A closer look at the technologies used by New Biotic
Top Business Services Companies
Frequently Asked Questions Regarding New Biotic
New Biotic, Inc. is focused on developing innovative biotherapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS), particularly their promising product RaphaLX. The company is exploring a new hypothesis regarding the relationship between muscular atrophy and motor neuron degeneration in ALS, aiming to identify potential therapeutic targ... Read More